All lobbying filings
Buchanan Ingersoll & Rooney PC
Buchanan Ingersoll & Rooney PC filed a Q4 report for Bright Path Labs on January 20, 2026, reporting $30,000 in lobbying income.
Lobbying for Bright Path Labs · Pharmaceutical company
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
North Carolina
Lobbyists on this filing
1
-
AMANDA LINCOLNPreviously held: Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
Government bodies contacted
7
Lobbying activity
6
Develop and execute a government relations strategy on issues relevant to Bright Path Labs.
Develop and execute a government relations strategy on issues relevant to Bright Path Labs.
Develop and execute a government relations strategy on issues relevant to Bright Path Labs.
Develop and execute a government relations strategy on issues relevant to Bright Path Labs.
Develop and execute a government relations strategy on issues relevant to Bright Path Labs.
Develop and execute a government relations strategy on issues relevant to Bright Path Labs.